BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PLX-61639 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PLX-61639\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07284186-2687@assetmemo.bio
DTSTAMP:20261121T005653Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:PLX-61639: Phase 1 readout est. (NCT07284186)
DESCRIPTION:PLX-61639\, phase 1.\nStudy: First-in-Human Study of PLX-61639 
 in Locally Advanced or Metastatic Solid Tumors\nEstimated primary completi
 on: December 2029. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pl
 x-61639#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07284186
URL:https://assetmemo.bio/drug/plx-61639#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
